CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $325,133,913 | -21.1% | 7,163,118 | -2.4% | 2.49% | -8.8% |
Q2 2023 | $411,980,394 | +14.0% | 7,338,447 | -8.2% | 2.73% | +9.8% |
Q1 2023 | $361,396,203 | +13.5% | 7,990,188 | +2.0% | 2.48% | -9.9% |
Q4 2022 | $318,286,736 | -40.9% | 7,829,932 | -5.0% | 2.76% | -26.5% |
Q3 2022 | $538,381,000 | -4.7% | 8,238,422 | -15.3% | 3.75% | +12.4% |
Q2 2022 | $564,758,000 | -4.3% | 9,728,831 | +3.4% | 3.34% | +35.5% |
Q1 2022 | $590,376,000 | -14.3% | 9,405,371 | +3.5% | 2.46% | +18.3% |
Q4 2021 | $688,778,000 | -18.9% | 9,089,168 | +19.8% | 2.08% | +2.1% |
Q3 2021 | $849,064,000 | -32.6% | 7,585,674 | -2.4% | 2.04% | -13.0% |
Q2 2021 | $1,258,876,000 | +24.6% | 7,776,119 | -6.2% | 2.34% | +16.7% |
Q1 2021 | $1,010,179,000 | -36.6% | 8,290,350 | -20.4% | 2.01% | -52.7% |
Q4 2020 | $1,594,331,000 | +125.4% | 10,412,976 | +23.1% | 4.24% | +1.1% |
Q3 2020 | $707,370,000 | +48.5% | 8,457,320 | +30.4% | 4.20% | -18.1% |
Q2 2020 | $476,454,000 | +162.1% | 6,483,251 | +51.3% | 5.12% | +13.1% |
Q1 2020 | $181,754,000 | +0.9% | 4,285,632 | +44.9% | 4.53% | -0.3% |
Q4 2019 | $180,074,000 | +57.9% | 2,956,635 | +6.3% | 4.54% | +82.5% |
Q3 2019 | $114,040,000 | -11.1% | 2,782,140 | +2.1% | 2.49% | -23.0% |
Q2 2019 | $128,317,000 | +77.6% | 2,724,349 | +34.7% | 3.23% | +56.6% |
Q1 2019 | $72,262,000 | +90.9% | 2,023,017 | +52.7% | 2.06% | +34.4% |
Q4 2018 | $37,858,000 | -41.3% | 1,325,110 | -8.8% | 1.54% | -21.1% |
Q3 2018 | $64,467,000 | +134.9% | 1,453,590 | +211.2% | 1.95% | +93.6% |
Q2 2018 | $27,449,000 | +727.8% | 467,140 | +544.0% | 1.01% | +509.7% |
Q1 2018 | $3,316,000 | +349.9% | 72,534 | +131.1% | 0.16% | +179.7% |
Q4 2017 | $737,000 | +257.8% | 31,388 | +143.5% | 0.06% | +47.5% |
Q2 2017 | $206,000 | – | 12,888 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |